The size of the Cell Culture Market in the Asia Pacific was worth USD 4.45 billion in 2021 and estimated to be growing at a CAGR of 12.12%, to reach USD 7.89 billion by 2026 during the forecast period.
Cell culture is defined as the removal of cells from an animal or plant and the subsequent cultivation of the cells in an artificial environment. The cells may be removed from the tissue directly or by enzymatic action and are then transferred elsewhere to be proliferated.
Primary culture is the stage of the culture that is initially extracted and isolated. They eventually reach a stage where it occupies the entire substrate and at this stage, they are transferred into a new growth vessel with fresh growth medium so as to enable continued growth. This process is called subculture and the stage is called confluence. Culture conditions vary, but in general, it consists of a substrate or medium, growth factors, hormones, gases such as carbon dioxide and oxygen and a regulated physio-chemical environment with set factors such as pH, osmotic pressure and temperature.
The major factors affecting the Asia-Pacific Cell Culture market include the growing demand for biopharmaceuticals and the rising prevalence of stem cell research. Biopharmaceuticals like vaccines and antibodies along with the growing healthcare costs are predicted to stimulate the demand for the cell culture items. The growing area of stem cell research shows great scope for the development of the cell culture market. Heavy investments made in stem cell research and organ transplantation are expected to drive the market in the coming years.
The market is impeded by the rising ethical concerns due to the use of animal sources in cell cultures. Regulatory bodies worldwide are taking steps regarding the same and enforcing stringent standards for cell culture. The high cost of cell biology research is another restraint for the growth of the market.
This research report has been segmented and sub-segmented into the following categories:
Regionally, the Asia-Pacific cell culture market is majorly driven by increased attention to R & D activities and the growth of the local healthcare industry and high unmet clinical needs. The growing demand for cell culture media and the rise of biopharmaceutical research are driving the rise of the industry.
The Asia Pacific region is expected to show the fastest growth during the forecast period. This could be due to higher healthcare costs, higher per capita income, and improved economic conditions in countries such as India and China. Thanks to advanced research on stem cell therapy, Japan also has significant room for growth. This trend is expected to benefit the entire Asia Pacific market in the future.
The Asia Pacific region is expected to show the highest growth during the study period. There are many clinical research organizations and biopharmaceutical companies targeting drug discovery and development in Asian countries such as China and India. The use of large regional genomic libraries, loose regulations on biologics development, and the development of healthcare infrastructure are some of the key factors supporting the growth of local industries.
Some of the prominent companies leading the APAC cell culture market profiled in the report are Thermo Fisher Scientific, GE Healthcare, Merck KGaA, Sartorius AG, Eppendorf AG, Lonza AG, Corning, Becton, Dickinson and Company, Promocell GmbH and Hi-Media Laboratories.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Product
5.1.1 Introduction
5.1.2 Equipment
5.1.3 Consumables
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Application
5.2.1 Introduction
5.2.2 Biopharmaceutical
5.2.2.1 Vaccine Production
5.2.2.2 Diagnostics
5.2.2.3 Recombinant Therapeutic Proteins
5.2.3 Cancer Research
5.2.4 Stem Cell Technologies
5.2.5 Drug Screening and Development
5.2.6 Tissue Engineering & Regenerative Medicine
5.2.7 Other Applications
5.2.8 Y-o-Y Growth Analysis, By Application
5.2.9 Market Attractiveness Analysis, By Application
5.2.10 Market Share Analysis, By Application
5.3 End User
5.3.1 Introduction
5.3.2 Pharmaceutical and Biotechnology Companies
5.3.3 Research Institutes
5.3.4 Y-o-Y Growth Analysis, By End User
5.3.5 Market Attractiveness Analysis, By End User
5.3.6 Market Share Analysis, By End User
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Application
6.1.3.4 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Application
6.1.4.4 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Application
6.1.5.4 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five Analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Thermo Fisher Scientific
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 GE Healthcare
8.3 MerckKgA
8.4 Sartorius AG
8.5 Eppendorf AG
8.6 Lonza AG
8.7 Corning
8.8 Becton, Dickinson and Company
8.9 Promocell GmbH
8.10 Hi-Media Laboratories
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
Appendix
Related Reports
Apr 2021
